BioSpace News Archive

United Therapeutics Corporation announced its financial results for the quarter ended June 30, 2020.

On Thursday, July 30, BIPOC leaders and life science experts will convene for Diversity Dialogue: #BeTheChange.

EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, will report results for its second quarter 2020 on Wednesday, August 5, 2020.

Casdin Capital leads the $50M extension; funding will support commercial launch of SYNTAX™ the world’s first enzymatic DNA printer.

Luciole Medical AG, a Swiss medical technology company, and Hôpital Fondation Adolphe de Rothschild announce a collaboration in brain metabolism monitoring research.

Innate Pharma SA announced the publication of a Nature paper entitled, “Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis,” authored by Innate researchers in partnership with scientists from Hôpitaux Universitaires de Marseille AP-HM, Laveran Hospital, Aix Marseille University, the Centre d’Immunologie de Marseille-Luminy and Marseille Immunopole/AP-HM immunoprofiling laboratory at La Timone Hospital.

Melbourne-based, clinical-stage biopharmaceutical company Dimerix has reported excellent results from the clinical trial of its drug candidate DMX-200, which is aimed at a rare kidney disease called focal segmental glomerulosclerosis, or FSGS.

Boston Scientific Corporation generated sales of $2.003 billion during the second quarter of 2020.

Executive Management to Host Conference Call on August 6, 2020 at 8:30 a.m. ET

Dr. Reddy’s Laboratories Ltd. announced its consolidated financial results for the quarter ended June 30, 2020.